P1136 TRIPLE THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN IN A REAL-LIFE SETTING: IS IT POSSIBLE TO ACHIEVE SVR RATES COMPARABLE TO PIVOTAL TRIALS?

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 60; no. 1; pp. S460 - S461
Main Authors Buggisch, P, Schober, A, Bruch, H.R, Antoni, C, Loehr, H, Herrmann, A, Steffens, H, Moog, G, Haessner, J, Hoerster, H.-G, John, C, Schlueter, H.-J, Link, R, Heyne, R, Spengler, U, Alshuth, U, Hueppe, D
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.04.2014
Subjects
Gastroenterology and Hepatology
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(14)61296-4